UltraPlasma™ Multi-Platform Plasma Systems for Hemangioma Treatment

Introduction

Hemangiomas—benign vascular tumors characterized by an abnormal proliferation of blood vessels—pose both aesthetic and medical challenges. Traditionally managed with laser therapy, corticosteroids, or surgical intervention, modern dermatology now embraces plasma medicine as a revolutionary alternative. UltraPlasma™ introduces a next-generation, multi-platform plasma system that integrates arc plasma, argon plasma, and helium plasma, controlled via proprietary software-hardware output spectrum modulation. This system targets the epidermal, dermal, and hypodermal vasculature, improving outcomes through precision oxidation and gas-mediated modulation.

1. UltraPlasma™ Composition & Output Control

1.1. UltraPlasma™ Arc Plasma Mode

• High-energy discharge.

• Induces rapid vascular coagulation.

• Penetrates dermal capillaries for localized clotting of hemangioma vessels.

1.2. UltraPlasma™ Argon Plasma Mode

• Inert, medium-penetration plasma.

• Stabilizes discharge along tissue surfaces.

• Improves ion transport through dermis to capillary loops.

1.3. UltraPlasma™ Helium Plasma Mode

• Cold, shallow-penetrating plasma.

• Increases epidermal biocompatibility.

• Facilitates nitric oxide (NO) and ozone delivery.

2. UltraPlasma™ Unique Output Spectrum

• Controlled via proprietary firmware.

• Software modulates frequency (20–200 kHz) and plasma polarity, adjusting the emission spectrum dynamically based on skin impedance and hemangioma vascularity.

• Smart sensor mapping adjusts gas delivery in real time for ozone (O₃), nitric oxide (NO), and reactive oxygen/nitrogen species (RONS).

3. Clinical Action Mechanism

• Targeted Emission: The UltraPlasma™ probe emits a tailored plasma beam directly over the hemangioma.

• Gas Activation: Ozone and NO are released, initiating oxidative stress in hemangioma capillaries.

• Vascular Collapse: UltraPlasma™ arc plasma coagulates abnormal vessels, reducing tumor bulk.

• Dermal Modulation: UltraPlasma™ argon and helium plasmas regulate inflammatory markers and accelerate healing.

• Epidermal Safety: Controlled thermal load prevents epidermal scarring or burns.

4. Biological Effects by Skin Layer

5. Biochemical Gases & Effects

• Ozone (O₃): Enhances redox activity, oxidizes blood vessel walls.

• Nitric Oxide (NO): Regulates vasodilation, modulates immune cells.

• Other RONS: Promote fibroblast migration, tissue remodeling.

6. Treatment Outcomes

⌘Conclusion⌘

UltraPlasma™ transforms hemangioma therapy through plasma-guided vascular oxidation, smart thermal control, and multigas modulation. It offers a minimally invasive, fast-recovery alternative to lasers and surgery, making it ideal for dermatologists, pediatric cases, and vascular specialists aiming for precision without scarring.

For clinical protocols, spectrum settings, and visual assessments, refer to the supplementary technical guide or contact the UltraPlasma™ clinical support team.

Shortcut for our Goals!

▼